Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion type Assertion NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_head.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion evidence source_evidence_literature NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion SIO_000772 23575477 NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion wasDerivedFrom befree-20150227 NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.
- NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_assertion wasGeneratedBy ECO_0000203 NP379646.RAWJ8C5sGcl_t6lGr3ufb6zZ3Wc0ezdf8VrcpQCd-fxnA130_provenance.